754.5 596.1 26.6% 2,179.4 1,798.8 21.2% Management Discussion and Analysis, Q3/2018 Page 2/5 Jaymart Public Company Limited Q3/2018 Q3/2017 Change 9M/2018 9M/2017 Change MB MB % MB MB % Sales promotion
Change DOD BIOTECH PUBLIC COMPANY LIMITED เลขท ี111 หมู่ท ี2 ตําบลท่าจีน อําเภอเมืองสมุทรสาคร จังหวดัสมุทรสาคร 74000 111 Moo 2 TambonThachin, Amphurmuangsamutsakhon, Samutsakhon 74000 As of March 31, 2020
10.73% 30 September 2020 31 December 2019 Change DOD BIOTECH PUBLIC COMPANY LIMITED เลขที่ 111 หมู่ที่ 2 ตาํบลท่าจนี อาํเภอเมืองสมุทรสาคร จงัหวดัสมุทรสาคร 74000 111 Moo 2 TambonThachin
higher than those of 2019 The profit of the Q4–2020 did not align with the change in revenue when compare with Q3–2020 and Q4– 2019. Since in Q4–2020, the Company has a finance income of 25.5 MB, which has
festival in the 4thquarter of each year. Financial Analysis of the Company As at December 31, 2019, the Company financial position change from that of December 31, 2018, is presented and explained the
percent while subsidiary’s loss for the period at Baht 31 million. For Nine Months 2019 period, profit for the period of the Company excluded the change of provision of post employees benefit-net corporate
Quarter 1/2018 Page 5/8 Jay Mart Public Company Limited Q1/2017 Q1/2018 Change Million Baht % Million Baht % Value % Total Revenues 2,953.9 100.1% 3,112.8 100.0% 158.9 5.4% Cost of Sales 2,103.9 71.3
25.0% 908.8 33.1% 129.5 16.6% Selling Expenses 237.5 7.6% 222.4 8.1% -15.1 -6.4% Management Discussion and Analysis (MD&A) for Q1/2019 Page 4/6 Jaymart Public Company Limited Q1/2018 Q1/2019 Change MB